Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis

Modern Rheumatology

Volumn 16, Issue 1, 2006, Pages 20-23

  Izumi, Yasumori ^a   Tominaga, Masahiro ^b   Iwanaga, Nozomi ^a   Huang, Mingguo ^a   Tanaka, Fumiko ^a   Aratake, Kouichiro ^a   Arima, Kazuhiko ^a   Tamai, Mami ^a   Kamachi, Makoto ^a   Nakamura, Hideki ^a   Ida, Hiroaki ^a   Origuchi, Tomoki ^a   Kawakami, Atsushi ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nijigaoka Hospital   (Japan)

Author keywords

DAS28 CRP; Leukocytapheresis (LCAP); Rheumatoid arthritis (RA)

Indexed keywords

ANTIBIOTIC AGENT; BUCILLAMINE; C REACTIVE PROTEIN; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; MIZORIBINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTAPHERESIS; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL PNEUMONIA; JAPAN; LEUKAPHERESIS; LUNG TUBERCULOSIS; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644557122     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-005-0448-0     Document Type: Article

References (15)

1. IA Jaffe 1963 Comparison of the effect of plasmapheresis and penicillamine on the level of circulating rheumatoid factor Ann Rheum Dis 22 71-76 1:STN:280:CC2C2MnitFA%3D 13964452
2. DJ Wallace D Goldfinger R Gatti C Lowe P Fan R Bluestone 1979 Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis Arthritis Rheum 22 703-710 1:STN:280:CSaB3cbjtF0%3D 454499
3. J Karsh DG Wright JH Klippel JL Decker AB Deisseroth MW Flye 1979 Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis: Clinical effects Arthritis Rheum 22 1055-1059 1:STN:280:Bi%2BD38%2FjslQ%3D 486218
4. DG Wright J Karsh AS Fauci JH Klippel JL Decker JF O'Donnell 1981 Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation Blood 58 451-458 1:STN:280:Bi6B2MrpvFU%3D 7259834
5. DE Trentham JA Belli RJ Anderson JA Buckley EJ Goetzl JR David 1981 Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis N Engl J Med 305 976-982 1:STN:280:Bi2D3Mzlt1Y%3D 7024811
6. HE Paulus HI Machleder S Levine DT Yu NS MacDonald 1977 Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage Arthritis Rheum 20 1249-1262 1:STN:280:CSiB28nosVE%3D 302707
7. G Sirchia P Rebulla A Parravicini V Carnelli GA Gianotti F Bertolini 1987 Leukocyte depletion of red cell units at the bedside by transfusion through a new filter Transfusion 27 402-405 10.1046/ j.1537-2995.1987.27587320533.x 1:STN:280:BiiA38%2Fltlc%3D 3629670
8. T Hidaka K Suzuki Y Matsuki M Takamizawa-Matsumoto K Kataharada T Ishizuka 1999 Filtration leukocytapheresis therapy in rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial Arthritis Rheum 42 431-437 1:STN:280:DyaK1M7os1Khtw%3D%3D 10088764
9. Y Ueki S Yamasaki Y Kanamoto T Kawazu M Yano K Matsumoto 2000 Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis Rheumatology (Oxf) 39 165-171 1:STN:280:DC%2BD3c7ptVSnsA%3D%3D
10. Y Ueki K Eguchi 2005 Leukocytapheresis for therapy of rheumatoid arthritis (in Japanese) Nippon Rinsho 63 Suppl 1 649-652 15799436
11. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315-324 1:STN:280:BieC1M3nt1Q%3D 3358796
12. O Steinbrocker CH Traeger RC Batterman 1949 Therapeutic criteria in rheumatoid arthritis JAMA 140 659-662
13. MA Quinn PG Conaghan P Emery 2001 The therapeutic approach of early intervention for rheumatoid arthritis: What is the evidence? Rheumatology (Oxf) 40 1211-1220 1:STN:280:DC%2BD3MnmsFCmsA%3D%3D
14. VP Nell KP Machold G Eberl TA Stamm M Uffmann JS Smolen 2004 Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis Rheumatology (Oxf) 43 906-914 1:CAS:528:DC%2BD2cXlt1Wltr8%3D
15. FA van Gaalen J van Aken TW Huizinga GM Schreuder FC Breedveld E Zanelli 2004 Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis Arthritis Rheum 50 2113-2121 1:CAS:528:DC%2BD2cXmsVansLo%3D 15248208